TUCSON, Ariz., March 4, 2026 /PRNewswire/ — Delta Development Team, Inc., an industry leader in ruggedized thermal systems for medical and emergency applications, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,566,016 covering its groundbreaking Autonomous Portable Refrigeration Unit (APRU-6L).
BROOKLYN PARK, Minn., March 4, 2026 /PRNewswire/ — Airiver Medical, a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions, was granted designation as a Breakthrough Device from the U.S. Food and Drug Administration (FDA) for its Airiver Pulmonary Drug Coated Balloon (DCB) to treat central airway stenosis.
MINNETONKA, Minn., March 4, 2026 /PRNewswire/ — Monteris Medical, the leader in minimally invasive neurosurgical technology with its NeuroBlate® System, announced today that a newly published randomized prospective study in the distinguished journal Nature Communications suggests that laser interstitial thermal therapy (LITT) using NeuroBlate may enhance the effectiveness of the immunotherapy drug pembrolizumab (Keytruda®) for patients with recurrent high grade astrocytoma, including glioblastoma (GBM).
A team of University of Mississippi researchers is developing a way to use 3D-printed medicated patches to help close persistent sores and ulcers
A new King’s College London study introduces a brand-new imaging tracer that looks at how tumors use fats to fuel their growth
Oregon Health & Science University researchers have found that certain nerves that play an integral role in the body’s “fight or flight” stress response can support pancreatic tumor growth.
Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell model demonstrating that the virus that causes COVID-19 (SARS-CoV-2) can directly infect heart tissue, providing new insight into why some people experience serious heart complications during and after infection.
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
OSLO, Norway, March 3, 2026 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that its core product APL-1702 (trade name: CEVIRA®), has received the Drug Registration Certificate from China’s National Medical Products Administration (NMPA), enabling commercial launch in China.
LILSE, Ill., March 3, 2026 /PRNewswire/ — Hubly Surgical has been awarded a Breakthrough Technology Designation for Neurosurgical Products with Premier, Inc. Premier offers Breakthrough Technology designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes and operational efficiencies.